Overview
Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2027-06-30
2027-06-30
Target enrollment:
Participant gender: